Stock Scorer

Incannex Healthcare Inc. (IXHL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 30K 60K 90K Q1 '25: 74K Q2 '25: 12K Q3 '25: 0 Q4 '25: 0 Q1 '25 Q2 '25 Q3 '25 Q4 '25

Operating Income Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q2 '23: -3.6M Q3 '23: -3.7M Q4 '23: -4.2M Q1 '24: -4.9M Q2 '24: -8M Q3 '24: -7.4M Q4 '24: -9.7M Q1 '25: -6.3M Q2 '25: -5M Q3 '25: -5M Q4 '25: -7.5M Q1 '26: -6.8M Q2 '26: -7M Q3 '26: -4M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q2 '23: -2.9M Q3 '23: -3.6M Q4 '23: -4.2M Q1 '24: -726K Q2 '24: -5.2M Q3 '24: -6M Q4 '24: -6.5M Q1 '25: -5.4M Q2 '25: -5.9M Q3 '25: -4M Q4 '25: -31.6M Q1 '26: -6.4M Q2 '26: -6.5M Q3 '26: -3.9M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

Operating Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '23: -2.7M Q4 '23: -2.6M Q1 '24: -5.7M Q2 '24: -2.1M Q3 '24: -4.4M Q4 '24: -3.6M Q1 '25: -2.2M Q2 '25: -5.6M Q3 '25: -3.2M Q4 '25: -1.5M Q1 '26: -9.2M Q2 '26: -4.6M Q3 '26: -2.5M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26

Free Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q3 '23: -2.8M Q4 '23: -2.8M Q1 '24: -6M Q2 '24: -2.2M Q3 '24: -4.4M Q4 '24: -3.6M Q3 '25: -3.2M Q4 '25: -1.5M Q1 '26: -9.2M Q2 '26: -4.6M Q3 '26: -2.5M Q3 '23 Q1 '24 Q3 '24 Q3 '25 Q1 '26 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q2 '23: 15.4M Q3 '23: 15.9M Q1 '24: 15.9M Q2 '24: 15.9M Q3 '24: 15.9M Q1 '25: 17.6M Q2 '25: 17.6M Q3 '25: 654.4K Q1 '26: 310.3M Q2 '26: 349.5M Q3 '26: 12.3M Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q2 '24: -1.02 Q3 '24: -1.18 Q4 '24: -1.18 Q1 '25: -1.39 Q2 '25: -1.39 Q3 '25: -7.20 Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for IXHL: Gross Profit, Cost of Revenue. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.